SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    A. Sanchís-Bonet, F. Ortiz-Vico, N. Morales-Palacios, M. Sánchez-Chapado, Asociación entre síndrome metabólico y cáncer de próstata: efecto sobre su agresividad y progresión, Actas Urológicas Españolas, 2015, 39, 3, 154

    CrossRef

  2. 2
    Bimal Bhindi, Jennifer Locke, Shabbir M.H. Alibhai, Girish S. Kulkarni, David S. Margel, Robert J. Hamilton, Antonio Finelli, John Trachtenberg, Alexandre R. Zlotta, Ants Toi, Karen M. Hersey, Andrew Evans, Theodorus H. van der Kwast, Neil E. Fleshner, Dissecting the Association Between Metabolic Syndrome and Prostate Cancer Risk: Analysis of a Large Clinical Cohort, European Urology, 2015, 67, 1, 64

    CrossRef

  3. 3
    L. Balssa, J. Pastori, J. Lillaz, M. Panouillères, G. Guichard, S. Bernardini, E. Chabannes, H. Bittard, A. Thiery-Vuillemin, F. Kleinclauss, Effets de l’obesité sur les résultats anatomopathologiques de la prostatectomie totale et sur la survie sans recidive biologique, Progrès en Urologie, 2015, 25, 7, 420

    CrossRef

  4. 4
    Audrey Blanc-Lapierre, Andrea Spence, Pierre I. Karakiewicz, Armen Aprikian, Fred Saad, Marie-Élise Parent, Metabolic syndrome and prostate cancer risk in a population-based case–control study in Montreal, Canada, BMC Public Health, 2015, 15, 1

    CrossRef

  5. 5
    Jian-Qin Zhang, Hui Geng, Mao Ma, Xun-Yi Nan, Bin-Wu Sheng, Metabolic Syndrome Components are Associated with Increased Prostate Cancer Risk, Medical Science Monitor, 2015, 21, 2387

    CrossRef

  6. 6
    Katharine N. Sourbeer, Lauren E. Howard, Gerald L. Andriole, Daniel M. Moreira, Ramiro Castro-Santamaria, Stephen J. Freedland, Adriana C. Vidal, Metabolic syndrome-like components and prostate cancer risk: results from the Reduction by Dutasteride of Prostate Cancer Events (REDUCE) study, BJU International, 2015, 115, 5
  7. 7
    L C Macleod, L J Chery, E Y C Hu, S B Zeliadt, S K Holt, D W Lin, M P Porter, J L Gore, J L Wright, Metabolic syndrome, dyslipidemia and prostate cancer recurrence after primary surgery or radiation in a veterans cohort, Prostate Cancer and Prostatic Disease, 2015, 18, 2, 190

    CrossRef

  8. 8
    Rhonda Arthur, Alejo Rodríguez-Vida, Giorgia Zadra, Henrik Møller, Mieke Van Hemelrijck, Serum lipids as markers of prostate cancer occurrence and prognosis?, Clinical Lipidology, 2015, 10, 2, 145

    CrossRef

  9. 9
    A. Sanchís-Bonet, F. Ortiz-Vico, N. Morales-Palacios, M. Sánchez-Chapado, The association between metabolic syndrome and prostate cancer: Effect on cancer aggressiveness and progression, Actas Urológicas Españolas (English Edition), 2015, 39, 3, 154

    CrossRef

  10. You have free access to this content10
    Ignacio F. San Francisco, Pablo A. Rojas, William C. DeWolf, Abraham Morgentaler, Low free testosterone levels predict disease reclassification in men with prostate cancer undergoing active surveillance, BJU International, 2014, 114, 2
  11. 11
    J. Morote, J. Ropero, J. Planas, A. Celma, J. Placer, R. Ferrer, I. de Torres, Metabolic syndrome in patients with prostate cancer undergoing androgen suppression, Actas Urológicas Españolas (English Edition), 2014, 38, 5, 285

    CrossRef

  12. 12
    J. Morote, A. Celma, J. Planas, J. Placer, C. Konstantinidis, I. Iztueta, I.M. de Torres, M. Oliván, J. Reventós, A. Doll, Sedentarism and overweight as risk factors for the detection of prostate cancer and its aggressiveness, Actas Urológicas Españolas (English Edition), 2014, 38, 4, 232

    CrossRef

  13. 13
    J. Morote, A. Celma, J. Planas, J. Placer, C. Konstantinidis, I. Iztueta, I.M. de Torres, M. Oliván, J. Reventós, A. Doll, Sedentarismo y sobrepeso como factores de riesgo en la detección del cáncer de próstata y su agresividad, Actas Urológicas Españolas, 2014, 38, 4, 232

    CrossRef

  14. 14
    J. Morote, J. Ropero, J. Planas, A. Celma, J. Placer, R. Ferrer, I. de Torres, Síndrome metabólico en pacientes con cáncer de próstata sometidos a supresión androgénica, Actas Urológicas Españolas, 2014, 38, 5, 285

    CrossRef

  15. 15
    Mustafa Kayali, Melih Balci, Yilmaz Aslan, Ovunc Bilgin, Ozer Guzel, Altug Tuncel, Ali Atan, The Relationship Between Prostate Cancer and Presence of Metabolic Syndrome and Late-onset Hypogonadism, Urology, 2014, 84, 6, 1448

    CrossRef

  16. 16
    K. Esposito, P. Chiodini, A. Capuano, G. Bellastella, M. I. Maiorino, E. Parretta, A. Lenzi, D. Giugliano, Effect of metabolic syndrome and its components on prostate cancer risk: Meta-analysis, Journal of Endocrinological Investigation, 2013, 36, 2, 132

    CrossRef

  17. 17
    Yuan-Yuan Qu, Bo Dai, Yun-Yi Kong, Kun Chang, Ding-Wei Ye, Xu-Dong Yao, Shi-Lin Zhang, Hai-Liang Zhang, Wei-Yi Yang, Influence of obesity on localized prostate cancer patients treated with radical prostatectomy, Asian Journal of Andrology, 2013, 15, 6, 747

    CrossRef

  18. 18
    B.J. Schmitz-Dräger, G. Lümmen, E. Bismarck, C. Fischer, Metabolisches Syndrom und Prostatakarzinom, Der Urologe, 2013, 52, 6, 842

    CrossRef

  19. 19
    Spiros D Garbis, Paul A Townsend, Proteomics of human prostate cancer biospecimens: the global, systems-wide perspective for Protein markers with potential clinical utility, Expert Review of Proteomics, 2013, 10, 4, 337

    CrossRef